Uri Tabori - Genetic Mutations

Author Information

Uri Tabori is affiliated with the Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada. He is also associated with The Arthur and Sonia Labatt Brain Tumour Research Centre and the Division of Hematology/Oncology at the same institution. His work primarily focuses on the genetic and genomic biology of pediatric cancers.

Research Contributions

Uri Tabori has made significant contributions in the field of genetics, particularly in pediatric oncology. His research spans a wide array of topics including genomic predictors of response to PD-1 inhibition in children, immune checkpoint inhibition, molecular testing for BRAF fusion in pediatric low-grade glioma, and the transcriptional landscape of Shh medulloblastoma. His work has been pivotal in understanding cancer predisposition syndromes, the profiling of glioblastomas, and the differentiation of BRAF-mutated and BRAF-fused tumors, among other areas.

Aliases

U. Tabori is also known by the aliases U Tabori and Uri Tabori.

Publication and Citation Metrics

Metric	Value
Citation Count	23,096
h-index	70
Paper Count	450

Publications:

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

DOI: 10.1038/s41591-021-01581-6

Year: 2022

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

DOI: 10.1200/PO.21.00286

Year: 2022

Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma

DOI: 10.1186/s12887-021-03069-1

Year: 2022

Abstract 1165: Complementary diagnostics for precision targeting of cellular pathways

DOI: 10.1158/1538-7445.AM2021-1165

Year: 2021

Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of BRAF-Mutated and BRAF-Fused Tumors

DOI: 10.3174/ajnr.A6998

Year: 2021

Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.

DOI: 10.1001/jamaoncol.2021.4536

Year: 2021

Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

DOI: 10.1007/s00401-021-02302-6

Year: 2021

The transcriptional landscape of Shh medulloblastoma

DOI: 10.1038/s41467-021-21883-0

Year: 2021

Paediatric atypical choroid plexus papilloma: is adjuvant therapy necessary?

DOI: 10.1007/s11060-021-03843-2

Year: 2021

Life without mismatch repair

DOI: 10.1101/2021.04.14.437578

Year: 2021

How Are Insertion Mutations Detected?

Why is Sanger Sequencing Important in Studying Genetic Mutations?

Are All Silent Mutations Neutral?

How are Harmful Mutations Detected?

What Is the Future of Genetic Mutation Research?

What are Induced Mutations?

Are Synonymous Mutations Considered in Genetic Research?

What is Sickle Cell Trait?

How is Hemophilia Inherited?

What Research is Being Conducted?

Partnered Content Networks

Relevant Topics